Autism spectrum disorders: An overview on diagnosis and treatment

Revista Brasileira de Psiquiatria

Volumn 35, Issue SUPPL. 1, 2013, Pages

  Brentani, Helena ^a   de Paula, Cristiane Silvestre ^b,c   Bordini, Daniela ^b   Rolim, Deborah ^a   Sato, Fabio ^a   Portolese, Joana ^a   Pacifico, Maria Clara ^a   McCracken, James T ^d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autistic disorder; Diagnosis; Pervasive development disorders; Treatment

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHISTAMINIC AGENT; ARBACLOFEN; ARIPIPRAZOLE; ATOMOXETINE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; MELATONIN; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; METHYLPHENIDATE; OLANZAPINE; OXYTOCIN; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROIC ACID; ZIPRASIDONE;

AGGRESSION; APPETITE DISORDER; ARTICLE; ASPERGER SYNDROME; ATTENTION DEFICIT DISORDER; AUTISM; AUTISM DIAGNOSTIC OBSERVATION SCHEDULE; BEHAVIORAL SCIENCE; COGNITIVE THERAPY; COMPULSION; DROWSINESS; EDUCATION; EVALUATION; HUMAN; HYPERACTIVITY; IMPULSIVENESS; INSOMNIA; INTELLIGENCE; IRRITABILITY; LANGUAGE DISABILITY; LOW DRUG DOSE; META ANALYSIS (TOPIC); METABOLISM; NEUTROPENIA; PARENT; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETT SYNDROME; SCREENING; SEIZURE; SIDE EFFECT; SPEECH AND LANGUAGE ASSESSMENT; TRAINING; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

AGE FACTORS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EVIDENCE-BASED MEDICINE; HUMANS; MASS SCREENING;

EID: 84889654382     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-4446-2013-S104     Document Type: Article

References (119)

1. American Psychiatric Association. Manual diagnó stico e estati{dotless}́stico de transtornos mentais: texto revisado (DSM-IV-TR). Porto Alegre: Artmed; 2002
2. Guthrie W, Swineford LB, Nottke C, Wetherby AM. Early diagnosis of autism spectrum disorders: stability and change in clinical diagnosis and symptom presentation. J Child Psychol Psychiatry 2012 Oct 9. [Epub ahead of print]
3. Lotter V. Epidemiology of autistic conditions in young children. Soc Psychiatry. 1966;1:124-35
4. Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009;65:591-8
5. Fombonne E. Past and future perspectives on autism epidemiology. In: Moldin SO, Rubenstein JLR, editors. Understanding autism: from basic neuroscience to treatment. Boca Raton: CRC Press; 2006. p. 25-45
6. Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcin C, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res. 2012;5:160-79
7. Fombonne E. A wrinkle in time: from early signs to a diagnosis of autism. J Am Acad Child Adolesc Psychiatry. 2009;48:463-4
8. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009;58:1-20
9. Paula CS, Ribeiro SH, Fombonne E, Mercadante MT. Brief report: prevalence of pervasive developmental disorder in Brazil: a pilot study. J Autism Dev Disord. 2011;41:1738-42
10. Klin A. Autism and Asperger syndrome: an overview. Rev Bras Psiquiatr. 2006;28:s3-11
11. Osterling JA, Dawson G, Munson J. Early recognition of 1-year-old infants with autism spectrum disorder versus mental retardation. Dev Psychopatol. 2002;14:239-51
12. Ozonoff S, Iosif AM, Baguio F, Cook IC, Hill MM, Hutman T, et al. A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry. 2010;49:256-66
13. Zwaigenbaum L, Bryson S, Lord C, Rogers S, Carter A, Carver L, et al. Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants. Pediatrics. 2009;123:1383-91
14. Rogers SJ. What are infant siblings teaching us about autism in infancy? Autism Res. 2009;2:125-37
15. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ. 2007;56:12-28
16. Ozonoff S. Editorial perspective: autism spectrum disorders in DSM- 5--an historical perspective and the need for change. J Child Psychol Psychiatry. 2012;53:1092-4
17. Barbaro J, Dissanayake C. Prospective identification of autism spectrum disorders in infancy and toddlerhood using developmental surveillance: the social attention and communication study. J Dev Behav Pediatr. 2010;31:376-85
18. Gray KM, Tonge BJ. Screening for autism in infants and preschool children with developmental delay. Aust N Z J Psychiatry. 2005;39:378-86
19. Robins DL, Fein D, Barton ML, Green JA. The Modified Checklist for Autism in Toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord. 2001;31:131-44
20. Krug DA, Arick J, Almond P. Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior. J Child Psychol Psychiatry. 1980;21:221-9
21. Berument SK, Rutter M, Lord C, Pickles A, Bailey A. Autism screening questionnaire: diagnostic validity. Br J Psychiatry. 1999;175:444-51
22. Schopler E, Reichler RJ, DeVellis RF, Daly K. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord. 1980;10:91-103
23. Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, Brophy SL, et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord. 2003;33:427-33
24. Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behavior Scales. Circle Pines: American Guidance Service, Inc.; 1984
25. Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985;89,485-91
26. Gurrieri F.Working up autism: the practical role of medical genetics. Am J Med Genet C Semin Med Genet. 2012;160C:104-10
27. Lord C, Rutter M, Dilavore P, Risi S. The autism diagnostic observation schedule: manual. Los Angeles: Western Psychological Corporation; 1999
28. Lord C, Rutter ML, Le Couteur A. Autism diagnostic interviewrevised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24:659-85
29. Becker MM, Wagner MB, Bosa CA, Schmidt C, Longo D, Papaleo C, et al. Translation and validation of Autism Diagnostic Interview- Revised (ADI-R) for autism diagnosis in Brazil. Arq Neuropsiquiatr. 2012;70:185-90
30. Frith U, Frith CD. Development and neurophysiology of mentalizing. Philos Trans R Soc Lond B Biol Sci. 2003;358:459-73
31. Levy SE, Mandell DS, Schultz RT. Autism. Lancet. 2009;374: 1627-1638
32. Sun J, Buys N. Early executive function deficit in preterm children and its association with neurodevelopmental disorders in childhood: a literature review. Int J Adolesc Med Health. 2012;24:291-9
33. Lord C, Shulman C, DiLavore P. Regression and word loss in autistic spectrum disorders. J Child Psychol Psychiatry. 2004;45:936-55
34. Paul R, Chawarska K, Fowler C, Cicchetti D, Volkmar F. "Listen my children and you shall hear": auditory preferences in toddlers with autism spectrum disorders. J Speech Lang Hear Res 2007;50:1350-64
35. Paul R. Communication development and assessment. In: Chawarska K, Klin A, Volkmar FR, editors. Autism spectrum disorders in infants and toddlers: diagnosis, assessment and treatment. New York: Guilford Press; 2008. p. 76-103
36. Paul R, Chawarska K, Klin A, Volkmar F. Dissociations in the development of early communication in autism spectrum disorders. In: Paul R. Language disorders from a developmental perspective: essays in honor of Robin Chapman. Hillsdale: Routledge, 2007. p. 163-95
37. Pickett E, Pullara O, O'Grady J, Gordon B. Speech acquisition in older nonverbal individuals with autism: a review of features, methods, and prognosis. Cogn Behav Neurol. 2009;22:1-21
38. Tager-Flusberg H, Paul R, Lord C: Language and communication in autism. In:Volkmar F, Paul R, Klin A, Cohen D, editors. Handbook of autism and pervasive developmental disorders, assessment, interventions, and policy. 3rd ed. New Jersey: John Wiley & Sons; 2005. p. 335-64
39. Paul R, Kimberly G. Development of language and communication. In: Hollander E, Kolevzon A; Coyle, JT. Textbook of autism spectrum disorders. Arlington: American Psychiatric Publishing; 2011. p. 147-58
40. Perissinoto J. Conhecimentos essenciais para atender bem as crianças com autismo. São José dos Campos: Pulso Editorial; 2003
41. Tomblin B. Co-morbidity of autism and SLI: kinds, kin and complexity. Int J Lang Commun Disord. 2011;46:127-37
42. Reisinger LM, Cornish KM, Fombonne E. Diagnostic differentiation of autism spectrum disorders and pragmatic language impairment. J Autism Dev Disord. 2011;41:1694-704
43. McGregor KK, Berns AJ, Owen AJ, Michels SA, Duff D, Bahnsen AJ, et al. Association between syntax and lexicon among children with or without ASD and language impairment. J Autism Dev Disord. 2012;42:35-47
44. Whitehouse AJ, Barry JG, Bishop DV. The broader phenotype of autism: a comparison with specific language impairment. J Child Psychol Psychiatry. 2007;48:822-30
45. Bishop DVM. Overlaps between autism and language impairment: phenomimicry or shared etiology? Behav Genet. 2010;40:618-29
46. Bishop DVM. Pragmatic language impairment: a correlate of SLI, a distinct subgroup or part of the continuum? In: Bishop DVM, Leonard LB, editors. Speech and language impairments in children: causes, characteristics, intervention ant outcome. Hove: Psychology Press; 2000. p. 99-114
47. Pastorello LM. Síndrome de Asperger. In: Fernandes FDM, Pastorello LM, Scheuer CI, editors. Fonoaudiologia nos distú rbios psiquiá tricos da infâ ncia. São Paulo: Lovise;1996. p. 45-59
48. Hage SRdV, Guerreiro MM. Distú rbio especi{dotless}́fico de linguagem: aspectos lingui{dotless}́sticos e neurobioló gicos. In: Fernandes FDM, Mendes BCA, Navas ALPGP, editors. Tratado de fonoaudiológia. 2nd ed. São Paulo: Roca; 2009. p. 323-9
49. Volkmar FR, Chawarska K. Autism in infants: an update. World Psychiatry. 2008;7:19-21
50. National Research Council. Committee on Educational Interventions for Children with Autism. Educating children with autism. Washington: National Academies Press; 2001
51. Corcoran J. Family treatment of preschool behavior problems. Res Soc Work Pract. 2000;10:547-88
52. Forehand R, Kotchick BA. Behavioral parent training: current challenges and potential solutions J Child Fam Stud. 2002;11:377-84
53. Wetherby AM, Woods J, Allen L, Cleary J, Dickison H, Lord C. Early indicators of autism spectrum disorders in the second year of life. J Autism Dev Disord. 2004;34:473-93
54. Wetherby AM, Woods J. Developmental approaches to treatment. In: Chawarska K, Klin A, Volkmar FR, editors. Autism spectrum disorders in infants and toddlers. New York: Guilford Press; 2008. p. 170-206
55. Wood JJ, Drahota A, Sze K, Har K, Chiu A, Langer DA. Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: a randomized, controlled trial. J Child Psychol Psychiatry. 2009;50:224-34
56. Cooper JO, Heron TE, Heward WL. Applied behavior analysis. 2nd ed. Upper Saddle River: Pearson Education; 2007
57. Soorya LV, Carpenter LA, Romanczyk RG. Applied behavior analysis. In: Hollander E, Kolevzon A, Coyle JT, editors. Textbook of autism spectrum disorders. Arlington: American Psychiatric Publishing; 2011. p. 525-36
58. Vismara LA, Rogers SJ. Behavioral treatments in autism spectrum disorder: what do we know? Annu Rev Clin Psychol. 2010;6:447-68
59. Warren Z, Veenstra-VanderWeele J, Stone W, Bruzek JL, Nahmias AS, Foss-Feig JH, et al. Agency for healthcare research and quality: Comparative effectiveness review No26 [Internet]. Therapies for children with autism spectrum disorders 2011 Apr [cited 20130 Jun 26]. http://www.ncbi.nlm.nih.gov/pubmedhealth/ PMH0015709/
60. Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics. 2010;125:e17-23
61. Lovaas OI: Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol 1987;55:3-9
62. Schopler E, Reichler RJ, Renner BR. The Childhood Autism Rating Scale (CARS): for diagnostic screening and classification of autism. New York: Irvington Publishers; 1986
63. Reaven J, Blakely-Smith A, Culhane-Shelburne K, Hepburn S. Group cognitive behavior therapy for children with high-functioning autism spectrum disorders and anxiety: a randomized trial. J Child Psychol Psychiatry. 2012;53:410-9
64. Aman MG, Lam KS, Collier-Crespin A. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. J Autism Dev Disord. 2003;33:527-34
65. Esbensen AJ, Greenberg JS, Seltzer MM, Aman MG.A longitudinal investigation of psychotropic and non-psychotropic use among adolescents and young adults with autism spectrum disorders. J Autism Dev Disord. 2009;39:1339-49
66. Ghaziuddin M, Tsai L, Ghaziuddin N. Comorbidity of autistic disorder in children and adolescents. Eur Child Adolesc Psychiatry. 1992;1:209-13
67. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a populationderived sample. J Am Acad Child Adolesc Psychiatry. 2008;47:921-9
68. Kaplan G, McCracken JT. Psychopharmacology of autism spectrum disorders. Pediatr Clin North Am. 2012;59:175-87
69. Lecavalier L. Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification. J Autism Dev Disord. 2006;36:1101-4
70. Nazzer A. Psychopharmacology of autistic spectrum disorders in children and adolescents. Pediatr Clin North Am. 2011;58:85-97
71. Baghdadli A, Pascal C, Grisi S, Aussilloux C. Risk factors for selfinjurious behaviors among 222 young children with autistic disorders. J Intellect Disabil Res. 2003;47:622-7
72. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347:314-21
73. Canitano R, Scandurra V. Psychopharmacology in autism: an update. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:18-28
74. Troost PW, Lahuis BE, Steenhuis MP, Ketelaars CE, Buitelaar JK, van Engeland H. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. J Am Acad Child Adolesc Psychiatry. 2005;44:1137-44
75. Luby J, Mrakotsky C, Stalets MM, Belden A, Heffelfinger A, Williams M, et al. Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy. J Child Adolesc Psychopharmacol. 2006;16:575-87
76. Nagaraj R, Singhi P, Malhi P. Risperidone in children with autism: randomized, placebo-controlled, double-blind study. J Child Neurol. 2006;21:450-5
77. Pandina GJ, Bossie CA, Youssef E, Zhu Y, Dunbar F. Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord. 2007;37:367-73
78. Aman MG, Hollway JA, McDougle CJ, Scahill L, Tierney E, McCracken JT, et al. Cognitive effects of risperidone in children with autism and irritable behavior. J Child Adolesc Psychopharmacol. 2008;18:227-36
79. Gencer O, Emiroglu FN, Miral S, Baykara B, Baykara A, Dirik E. Comparison of long term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study. Eur Child Adolesc Psychiatry. 2008;17:217-25
80. Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics. 2004;114:e634-41
81. McDougle CJ, Stigler KA, Erickson CA, Posey D. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. J Clin Psychiatry. 2008;69:15-20
82. Siegel M, Beaulieu AA. Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence - based practice. J Autism Dev Disord. 2012;42:1592-605
83. Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009;48:1110-9
84. Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009;124:1533-40
85. Anderson LT, Campbell M, Adams P, Small AM, Perry R, Shell J. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Dev Disord. 1989;19: 227-39
86. Anderson LT, Campbell M, Grega DM, Perry R, Small AM, Green WH. Haloperidol in infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry. 1984;141:1195-202
87. Miral S, Gencer O, Inal-Emiroglu FN, Baykara B, Baykara A, Dirik E. Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial. Eur Child Adolesc Psychiatry. 2008;17:1-8
88. Horrigan JP, Barnhill LJ, Courvoisie HE. Olanzapine in PDD. J Am Acad Child Adolesc Psychiatry. 1997;36:1166-7
89. Heimann SW. High-dose olanzapine in an adolescent. J Am Acad Child Adolesc Psychiatry. 1999;38:496-8
90. Potenza MN, Holmes JP, Kanes SJ, McDougle CJ. Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study. J Clin Psychopharmacol. 1999;19:37-44
91. Malone RP, Cater J, Sheikh RM, Choudhury MS, Delaney MA. Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. J Am Acad Child Adolesc Psychiatry. 2001;40:887-94
92. Bonanno DG, Davydov L, Botts SR. Olanzapine-induced diabetes mellitus. Ann Pharmacother. 2001;35:563-5
93. Malone RP, Delaney MA, Hyman SB, Cater JR. Ziprasidone in adolescents with autism: an open-label pilot study. J Child Adolesc Psychopharmacol. 2007;17:779-90
94. Cohen SA, Fitzgerald BJ, Khan SR, Khan A. The effect of a switch toziprasidone in an adult population with autistic disorder: chart review of naturalistic, open-label treatment. J Clin Psychiatry. 2004;65:110-3
95. McDougle CJ, Kem DL, Posey DJ. Case series: use of ziprasidone for maladaptive symptoms in youths with autism. J Am Acad Child Adolesc Psychiatry. 2002;41:921-7
96. Martin A, Koenig K, Scahill L, Bregman J. Open-label quetiapineinthe treatment of children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol. 1999;9:99-107
97. Chen NC, Bedair HS, McKay B, Bowers MB Jr, Mazure C. Clozapine in the treatment of aggression in an adolescent with autistic disorder. J Clin Psychiatry. 2001;62:479-80
98. Kolevzon A, Mathewson KA, Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry. 2006;67:407-14
99. Soorya L, Kiarashi J, Hollander E. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2008;17:753-71
100. Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasseman S, et al. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neurophycopharmacology. 2005;30:582-9
101. King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, et al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry. 2009;66;583-90
102. McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry. 1996:53:1001-8
103. Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, et al. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. Am J Psychiatry. 2012;169:292-9
104. Goldstein S, Schewebach AJ. The comorbidity of pervasive developmental disorder and attention disorder: results of a retrospective chart review. J Autism Dev Disord. 2004;34:329-39
105. Aman MG, Farmer CA, Hollway J, Arnold LE. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2008;17:713-38
106. Nikolov R, Jonker J, Scahill L. Autistic disorder: current psychopharmacological treatments and areas of interest for future developments. Rev Bras Psiquiatr. 2006;28:s39-46
107. Quintana H, Birmaher B, Stedge D, Lennon S, Freed J, Bridge J, et al. Use of methylphenidate in the treatment of children with autistic disorder. J Autism Dev Disord. 1995;25:283-94
108. Handen BL, Johnson CR, Lubetsky M. Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. J Autism Dev Disord. 2000;30:245-55
109. Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62:1266-74
110. Eugene Arnold L; Children with Hyperactivity & ASD Research Treatment Study (CHARTS) Consortium. Atomoxetine reduces ADHD symptoms in children with autism spectrum disorder. Evid Based Ment Health. 2012;15:96
111. Harfterkamp M, van de Loo-Neus G, Minderaa RB, van der Gaag RJ, Escobar R, Schacht A, et al. A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2012;51:733-41
112. Souders MC, Mason TB, Valladares O, Bucan M, Levy SE, Mandell DS, et al. Sleep behaviors and sleep quality in children with autism spectrum disorders. Sleep. 2009;32:1566-78
113. Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol. 2011;53:783-92
114. Malow BA, Byars K, Johnson K, Weiss S, Bernal P, Goldman SE, et al. A practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders. Pediatrics. 2012;130:S106-24
115. Bolton PF, Carcani-Rathwell I, Hutton J, Goode S, Howlin P, Rutter M. Epilepsy in autism: features and correlates. Br J Psychiatry. 2011;198:289-94
116. Frye RE, Sreenivasula S, Adams JB. Traditional and non - traditional treatments for autism spectrum disorder with seizures: an on-line survey. BMC Pediatr. 2011;11:37
117. Hollander E, Chaplin W, Soorya L, Wasserman S, Novotny S, Rusoff J, et al. Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology. 2010;35:990-8
118. Rezaei V, Mohammadi MR, Ghanizadeh A, Sahraian A, Tabrizi M, Rezazadeh SA, et al. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1269-72
119. Fiedorowicz JG, Miller DD, Bishop JR, Calarge CA, Ellingrod VL, Haynes WG. Systematic review and meta-analysis of pharmacological interventions for weight gain from antipsychotics and mood stabilizers. Curr Psychiatry Rev. 2012;8:25-36.